The clinical impact of serum sLOX-1 level in coronary artery disease patients as inferred from its implication in the in vitro protective effects of metoprolol against hypoxic injury of HUVECs
29 August 2020 (00:00 - 00:00)
Organised by:
About the speaker
Jouf University, Sakaka (Saudi Arabia)
233 More presentations in this session
Diabetes and pre-infarct angina. Time to rethink comorbidities in the reperfusion-injury phenomenon?
Doctor M. Fontes Oliveira (Porto, PT)
Doctor M. Bigler (Bern, CH)
Doctor P. Eugenia (Rome, IT)
Doctor T. Silva (Lisbon, PT)
Assistant Professor C. Schiano (Naples, IT)
Access the full session
The Event
ESC Congress 2020
29 August - 1 September 2020
